NEW YORK – Novigenix said today that it has tapped Belgium-based startup bioinformatics firm BioLizard to develop an artificial intelligence-based algorithm to support the transition of its Colox immuno-transcriptomic RT-PCR product onto a new platform. The algorithm will also underlie new Novigenix products under development.